ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Utility Working Conference and Vendor Technology Expo (UWC 2022)
August 7–10, 2022
Marco Island, FL|JW Marriott Marco Island
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Latest Journal Issues
Nuclear Science and Engineering
Fusion Science and Technology
Holtec completes acquisition of Michigan’s Palisades and Big Rock Point
Holtec International announced on June 28 that it has completed the acquisition of the Palisades nuclear power plant and the Big Rock Point site from Entergy Corporation. The Nuclear Regulatory Commission approved the license transfer for the two sites, both located in Michigan, in December 2021.
Joseph Christensen (SHINE Medical Technologies)
Transactions | Volume 122 | Number 1 | June 2020 | Pages 489-489